Navin Fluorine International Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 19 Jul 2026 | Chemicals & Petrochemicals | Market Cap: ₹42.3K Cr

Strong growth momentum expected across all three business verticals: Specialty Chemicals, CDMO, and HPP, supported by ongoing capacity expansions and positive pricing trends (Pages 4, 6, 12). Navin Fluorine expects continued strong growth across all verticals driven by ongoing CAPEX projects and expanding capacities.

From Navin Fluorine International Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

₹8,206

Market Cap

₹42.3K Cr

P/E Ratio

53.1

How does Navin Fluorine International Ltd rank in Chemicals & Petrochemicals?

Compare Navin Fluorine International Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Navin Fluorine International Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹938 Cr, net profit ₹213 Cr.

Full financials →

📊 Revenue & Sales Performance

→Strong growth momentum expected across all three business verticals: Specialty Chemicals, CDMO, and HPP, supported by ongoing capacity expansions and positive pricing trends (Pages 4, 6, 12).
→Specialty Chemicals division achieved its highest-ever quarterly revenue; further growth expected with ramp-up of Nectar project and other pipeline products (Pages 6, 12, 18).
→CDMO is witnessing significant deal wins and balanced portfolio of early and late-stage molecules; aiming to fully utilize dedicated cGMP-4 plant capacity in FY27 and inch closer to $100 million revenue aspirational mark (Pages 18, 12).
→Agrochemical volume outlook looks positive in FY27 after two rough years, with good capacity utilization and pipeline of new molecules supporting volume growth (Page 16).
→Exports to EU and other geographies expected to rise as business expands into newer markets aided by trade agreements and competitive positioning (Page 17).
→Overall revenue growth: 47% YoY in Q3 FY26, with full year FY25 revenues surpassed in first nine months of FY26, indicating strong forward trajectory (Page 6).

📈 Profitability & Margins

→Navin Fluorine expects continued strong growth across all verticals driven by ongoing CAPEX projects and expanding capacities.
→Specialty Chemicals division has set a new high in quarterly revenue, indicating a solid growth run rate.
→CDMO business is ramping up, aiming for the aspirational $100 million revenue mark in the near future.
→The cGMP-4 phase-I plant is expected to reach full utilization within FY27, supporting revenue growth.
→EBITDA margins are expected to stabilize around 30% on an annualized basis, with operating leverage playing a significant role in earnings growth.
→The company anticipates balanced growth from early and late-stage molecules in CDMO, potentially accelerating revenue conversion.
→Earnings growth rate surpasses revenue growth due to strong operating leverage and margin improvements.
→Staff costs are expected to remain controlled at 7-8% of revenue, helping margin sustainability.
→Net debt-to-equity remains low at 0.03x, supporting disciplined growth financials.

See what Navin Fluorine International Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

→Completed Wave-1 CAPEX projects, including cGMP-4 Phase-1 facility and AHF project, both commissioned and commercial supplies started.
→Ongoing Wave-2 CAPEX projects on track: MPP debottlenecking, R-32 expansion, HFC expansion, and Chemours project.
→Nectar plant added; aiming to utilize full capacity by FY27.
→CDMO dedicated plant expected to be fully utilized in FY27.
→Focus on advanced materials and downstream fluorinated chemistries for new age industries, including semiconductors and data centers globally and in India.
→Emphasis on capacity expansion balanced with disciplined project execution.
→Future CAPEX will target electronic-grade AHF production and downstream applications to leverage semiconductor and solar opportunities.
→Chemours project expected to ramp up over FY27-FY29 with potential for additional larger CAPEX.
→Strategy includes increasing captive consumption of AHF to support niche chemistries and advanced materials growth.

💰 Fundraising & Capital Structure

→There is no explicit mention in the transcript of any current or future fundraising plans through debt or equity.
→The company indicates a disciplined approach to growth with a net debt-to-equity ratio of 0.03x as of December 31, FY25, reflecting low leverage.
→Ongoing CAPEX projects are progressing well, but financing details or plans for raising funds via new debt or equity are not disclosed.
→The focus seems to be on executing existing CAPEX and driving growth through operations and partnerships without indicating new fundraising.
→No announcements or indications of equity issuance or debt raising are made in the provided pages.

See what Navin Fluorine International Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

→Navin Fluorine International Limited has a strong pipeline of projects and order visibility across all verticals.
→The CDMO (Contract Development and Manufacturing Organization) business continues to build momentum with strong order visibility.
→The Specialty Chemicals division has achieved its highest-ever quarterly revenue, reflecting strong execution and deeper partnerships.
→Wave-1 CAPEX projects like AHF and cGMP-4 Phase-1 have been commissioned and are operational.
→Wave-2 projects including MPP debottlenecking, R-32 expansion, HFC expansion, and the Chemours project are on track for completion.
→The company is actively working on expanding capabilities and aiming for optimal utilization of new plants within FY27.
→Growth opportunities are backed by policy support like the Semiconductor Mission 2.0 and trade agreements enhancing order inflows.
→Overall, clear order visibility and a strong project pipeline support confidence in the company’s growth trajectory.

Key Metrics

What Navin Fluo.Intl.'s management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Clean Science & Technology Ltd (Q3 FY26)
Trade deal with Europe starting in FY '27 to potentially reduce tariffs (5.5%-12%), helping competitiveness against China. Key concall takeaways from Clean…
Aether Industries Ltd (Q3 FY26)
The company currently services Baker Hughes with 8 products in commercial production (Site 4) generating a run rate of INR 60 crores this quarter. Key concall…
Kesar Petroprod. (Q3 FY26)
Export markets constitute about 40% of sales, served through 7-8 distributors across geographies. Key concall takeaways from Kesar Petroprod.'s Q3 FY26…
Tata Chemicals (Q3 FY26)
Indian salt capacity expansion of 210 KT per annum with INR 515 crore investment is underway to meet growing demand. Key concall takeaways from Tata…

Compare:vs Pidilite Inds.vs SRF vs Linde India Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Navin Fluorine International Ltd Q3 FY26 results?

What is Navin Fluorine International Ltd share price analysis?

Navin Fluorine International Ltd currently shows a neutral. The stock trades at a P/E of 53.1 with a market cap of ₹42,251 Cr. Investors should review the full earnings analysis for detailed insights.

Is Navin Fluorine International Ltd planning capital expenditure?

Completed Wave-1 CAPEX projects, including cGMP-4 Phase-1 facility and AHF project, both commissioned and commercial supplies started.

Keep Navin Fluorine International Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.